🔗 Share this article

The top legal official in Texas Ken Paxton is filing a lawsuit against the manufacturers of acetaminophen, claiming the firms concealed safety concerns that the pain reliever presented to pediatric brain development.

The lawsuit comes four weeks after Former President Trump publicized an unsubstantiated connection between taking acetaminophen - also known as acetaminophen - while pregnant and autism in young ones.

The attorney general is suing Johnson & Johnson, which once produced the drug, the only pain reliever recommended for expectant mothers, and Kenvue, which presently makes it.

In a declaration, he stated they "betrayed America by profiting off of pain and promoting medication without regard for the dangers."

The manufacturer asserts there is no credible evidence linking Tylenol to autism.

"These companies misled for generations, deliberately risking countless individuals to increase profits," the attorney general, from the Republican party, said.

The company said in a statement that it was "deeply concerned by the spread of false claims on the security of paracetamol and the likely effects that could have on the health of women and children in America."

On its online platform, the company also said it had "regularly reviewed the applicable studies and there is insufficient valid information that demonstrates a established connection between taking acetaminophen and autism."

Groups speaking for physicians and health professionals share this view.

The American College of Obstetricians and Gynecologists has said acetaminophen - the primary component in Tylenol - is among limited choices for pregnant women to address discomfort and elevated temperature, which can create significant medical dangers if ignored.

"In more than two decades of investigation on the use of paracetamol in pregnancy, no reliable research has successfully concluded that the usage of paracetamol in any period of gestation causes neurodevelopmental disorders in offspring," the group stated.

This legal action cites current declarations from the Trump administration in claiming the medication is allegedly unsafe.

In recent weeks, the former president generated worry from medical authorities when he advised expectant mothers to "resist strongly" not to use Tylenol when sick.

The FDA then released a statement that physicians should think about restricting the consumption of Tylenol, while also stating that "a causal relationship" between the medication and autism in minors has not been proven.

Health Secretary Robert F Kennedy Jr, who manages the Food and Drug Administration, had vowed in spring to undertake "extensive scientific investigation" that would identify the origin of autism in a short period.

But authorities warned that discovering a single cause of autism - thought by researchers to be the consequence of a intricate combination of genetic and surrounding conditions - would not be simple.

Autism spectrum disorder is a category of enduring cognitive variation and impairment that impacts how individuals experience and relate to the environment, and is identified using physician assessments.

In his lawsuit, the attorney general - who supports Trump who is running for the Senate - asserts Kenvue and Johnson & Johnson "intentionally overlooked and sought to suppress the evidence" around acetaminophen and autism spectrum disorder.

This legal action aims to force the firms "destroy any commercial messaging" that asserts acetaminophen is safe for pregnant women.

The court case mirrors the grievances of a assembly of parents of minors with autism and ADHD who filed suit against the makers of acetaminophen in recently.

Judicial authorities rejected the case, stating studies from the family's specialists was lacking definitive proof.